Blood Clot Formation

Preview:

DESCRIPTION

Blood Clot Formation. ATLAS ACS 2—TIMI 51 Design. ATLAS-2 Patients With Biomarker Elevation, n = 12,626. ATLAS-2 Patients With Biomarker Elevation, n = 12,626. APPRAISE-2. ATLAS-ACS TIMI 46. Newer Antiplatelet Agents. WOEST Efficacy End Points. WOEST Bleeding Events. - PowerPoint PPT Presentation

Citation preview

Blood Clot Formation

ATLAS ACS 2—TIMI 51Design

ATLAS-2Patients With Biomarker Elevation, n =

12,626

ATLAS-2Patients With Biomarker Elevation, n =

12,626

APPRAISE-2

ATLAS-ACS TIMI 46

Newer Antiplatelet Agents

WOESTEfficacy End Points

WOESTBleeding Events

Recommended